Search for: "Andrew Ittleman"
Results 1 - 6
of 6
Sorted by Relevance
|
Sort by Date
23 Mar 2007, 12:50 pm
Humphrey, and Andrew S. [read post]
15 Feb 2024, 9:05 pm
EDITOR’S CHOICE In an essay in The Regulatory Review, Andrew Ittleman, a partner at Fuerst Ittleman David & Joseph, proposed steps FDA should take r to improve the regenerative medicine industry following the enactment of the 21st Century Cures Act in 2016. [read post]
21 Dec 2011, 12:43 pm
“They have to blow up the bill now, investigate later system,” agreed Andrew Ittleman, a white collar criminal defense attorney at Fuerst Ittleman in Miami. [read post]
26 Dec 2021, 9:05 pm
Strengthening the Stem Cell Industry Through Better Regulation April 6, 2021 | Andrew Ittleman, Fuerst Ittleman David & Joseph, PL FDA should take steps to strengthen the regenerative medicine industry. [read post]
25 Dec 2017, 9:40 pm
The Regulatory Review is pleased to highlight our top fifty regulatory essays of 2017 authored by outside contributors. [read post]
25 Dec 2017, 9:40 pm
The Regulatory Review is pleased to highlight our top fifty regulatory essays of 2017 authored by outside contributors. [read post]